A group of concerned stakeholders advocating for broader access to diverse COVID-19 vaccine options for Canadians, particularly those beyond the mRNA vaccines currently dominating the public offering wrote a letter to the Public Health Agency of Canada (PHAC), all the provinces/territories and immunization providers to address the pressing need for enhanced COVID-19 awareness and education, increased availability and access to protein-based vaccines, such as Novavax, which are currently limited in distribution.